Study of Tamibarotene in Patients With ADPKD

NCT06289998 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: Tamibarotene
DRUG: Placebo

Sponsor

Rege Nephro Co., Ltd.